Novo Nordisk wraps up another weight management deal

9 May 2024
novo_nordisk_copenhagen_large

In a bid to retain its leadership position in the ever-expanding obesity sector, Novo Nordisk (NOV: N) has inked another research collaboration, adding to a string of M&A and licensing deals over the past couple of years.

Metaphore Biotechnologies, a Flagship-founded biotechnology company, today joined Flagship Pioneering in announcing a research collaboration with Novo Nordisk to develop up to two next-generation therapeutics for obesity management.

The collaboration is signed under the broader strategic partnership with the Danish diabetes and obesity giant and Flagship Pioneering to develop a portfolio of novel treatment approaches for cardiometabolic and rare diseases.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK

Company News Directory

Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight





More Features in Pharmaceutical